Sia Partners Acquires Latham BioPharm Group

ProductLife Group Acquires Halloran Consulting Group

October 17, 2024

Healthcare Services

ProductLife Group (PLG), a global life‑sciences consulting and outsourcing firm, has acquired Halloran Consulting Group, a U.S.-based life sciences consulting firm with offices in Boston and San Diego. The acquisition expands PLG’s regulatory, quality, clinical, and organizational capabilities while strengthening its presence in the North American market to better support pharmaceutical, biotech, and medical device clients.

Trinity Life Sciences Acquires CBPartners

October 7, 2021

Healthcare Services

Trinity Life Sciences has acquired New York–headquartered CBPartners to significantly scale its Value, Access and Pricing business, adding over 75 dedicated experts and expanding Trinity's presence in New York City, San Francisco and London. The acquisition augments Trinity's market access, pricing and commercial strategy capabilities to better support life sciences companies in bringing products to market and ensuring patient access globally.

Riverside Partners Combines Sequoia Biotech Consulting and Syner-G BioPharma Group

September 18, 2024

Healthcare Services

Boston-based private equity firm Riverside Partners has combined two of its portfolio companies, Sequoia Biotech Consulting and Syner-G BioPharma Group, into a single, integrated life‑sciences services business. The combined organization — bringing together regulatory, development, quality, and operational capabilities — has approximately 500 employees and will provide end-to-end solutions to pharmaceutical, biotechnology, and medical device clients.

The Lynx Group Acquires Upstream Partners

August 13, 2020

Healthcare Services

The Lynx Group has acquired Upstream Partners to form a new division focused on providing pharmaceutical and biotech clients with market-informed insights across product life cycles. The acquisition combines TLG's channels and ecosystems with Upstream Partners' relationships with key opinion leaders to enhance pre- and post-market strategy, launch readiness, and lifecycle management—particularly in oncology.

Pace Life Sciences Acquires Biopharma Global

September 8, 2022

Healthcare Services

Pace Life Sciences, a CDMO subsidiary of Pace, has acquired Biopharma Global, a Vienna, Virginia-based regulatory affairs consultancy that specializes in orphan and other high‑unmet‑need drug regulatory support. The acquisition expands Pace's regulatory strategy and submission capabilities for FDA and EMA filings, strengthening its end-to-end development and regulatory services for biotech and pharmaceutical clients.

Warburg Pincus–Lendlease JV Acquires ~S$1.6bn Singapore Life Sciences & R&D Property Portfolio

August 26, 2024

Real Estate

A joint venture platform established by Warburg Pincus and Lendlease, together with its managed investment vehicle LINO, acquired a ~S$1.6 billion portfolio of industrial life‑sciences, R&D and specialist facilities in Singapore. The assets—previously held by entities associated with Blackstone and Mr Lim Chap Huat (Soilbuild)—give the JV immediate scale in Singapore and support its strategy to build a market‑leading life sciences and R&D real estate platform in Asia Pacific.